D01.5
Carcinoma in situ of liver, gallbladder and bile ducts
Clinical Classification Guidelines
Inclusion Terms
- Carcinoma in situ of ampulla of Vater
Medical Intelligence & Overview
Carcinoma in situ (CIS) of the liver, gallbladder, and bile ducts is a non-invasive form of cancer that affects the cells lining these organs. The term 'in situ' indicates that the abnormal cells have not spread beyond their original location, making early detection and treatment crucial for preventing progression to invasive cancer. This condition can involve various parts of the biliary system, including the liver, gallbladder, bile ducts, and the ampulla of Vater, which is where the bile duct and pancreatic duct meet and drain into the small intestine.
Causes & Symptoms
Clinical Causes: Chronic inflammation of the liver or biliary system (e.g., due to hepatitis or primary sclerosing cholangitis) Chronic gallstones causing irritation and cellular changes Exposure to certain toxins and chemicals Chronic infection with liver flukes or viruses Genetic predisposition to biliary tract cancers History of other biliary tract diseases or previous cancers
Key Symptoms: Often asymptomatic in early stages, making detection challenging Jaundice (yellowing of the skin and eyes) in some cases Unexplained weight loss Persistent abdominal pain or discomfort in the upper right region Nausea and vomiting Abdominal mass or swelling Itching and skin changes due to bile flow obstruction Fever if infection develops secondary to biliary obstruction
Diagnostic & Treatment
Diagnosis Path: Imaging studies such as ultrasound, magnetic resonance cholangiopancreatography (MRCP), or computed tomography (CT) scans to visualize biliary structures Endoscopic procedures like endoscopic retrograde cholangiopancreatography (ERCP) for direct visualization and tissue sampling Biopsy of suspicious lesions obtained during endoscopy or imaging-guided procedures Blood tests assessing liver function and tumor markers like CA 19-9 Histopathological examination of tissue samples confirming carcinoma in situ
Treatment Protocols: Surgical resection to remove affected tissue, especially if the lesion is localized and accessible Endoscopic procedures to remove or ablate abnormal cells Liver transplantation in select cases involving extensive biliary tract involvement Adjunctive therapies such as photodynamic therapy (PDT) or radiotherapy for specific situations Ongoing surveillance with regular imaging and clinical assessments to monitor for progression
Clinical Advice & FAQs
Billing Guidance
Is D01.5 a billable ICD-10 code?
Yes, D01.5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D01.5?
Clinical documentation must specify the nature of Carcinoma in situ of liver, gallbladder and bile ducts and any associated comorbidities for accurate reporting.
Cite this Clinical Reference